Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story

被引：2
作者：
Guitart, Joan [1 ,2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA
[2] Northwestern Univ, Feinberg Med Sch, Dept Dermatol, 676 N St Clair,Ste 1750, Chicago, IL 60611 USA
来源：
JAMA DERMATOLOGY | 2023年 / 159卷 / 11期
关键词：
T-CELL LYMPHOMA; PROGRESSION;
D O I：
10.1001/jamadermatol.2023.3846
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1177 / 1178
页数：2
相关论文
共 14 条
  • [1] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Hamilton, Jennifer D.
    Graham, Neil M.
    Bieber, Thomas
    Rocklin, Ross
    Ming, Jeffrey E.
    Ren, Haobo
    Kao, Richard
    Simpson, Eric
    Ardeleanu, Marius
    Weinstein, Steven P.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    Suarez-Farinas, Mayte
    Hager, Melissa D.
    Stahl, Neil
    Yancopoulos, George D.
    Radin, Allen R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) : 130 - 139
  • [2] Berger CL, 2001, ANN NY ACAD SCI, V941, P106
  • [3] Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis
    Boesjes, Celeste M.
    van der Gang, Lian F.
    Bakker, Daphne S.
    ten Cate, Tess A.
    Spekhorst, Lotte S.
    de Graaf, Marlies
    van Dijk, Marijke R.
    de Bruin-Weller, Marjolein S.
    [J]. JAMA DERMATOLOGY, 2023, 159 (11) : 1240 - 1247
  • [4] Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients
    Espinosa, Maria L.
    Nguyen, Morgan T.
    Aguirre, Amaia Saenz
    Martinez-Escala, Maria Estela
    Kim, Jane
    Walker, Christina J.
    Pontes, David S.
    Silverberg, Jonathan I.
    Choi, Jaehyuk
    Pro, Barbara
    Pincus, Laura B.
    Guitart, Joan
    Zhou, Xiaolong A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 197 - 199
  • [5] Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
    Geskin, Larisa J.
    Viragova, Sara
    Stolz, Donna B.
    Fuschiotti, Patrizia
    [J]. BLOOD, 2015, 125 (18) : 2798 - 2805
  • [6] Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis A Phase 2b Randomized Clinical Trial
    Guttman-Yassky, Emma
    Blauvelt, Andrew
    Eichenfield, Lawrence F.
    Paller, Amy S.
    Armstrong, April W.
    Drew, Janice
    Gopalan, Ramanan
    Simpson, Eric L.
    [J]. JAMA DERMATOLOGY, 2020, 156 (04) : 411 - 420
  • [7] Long-standing Dermatitis Treated With Dupilumab With Subsequent Progression to Cutaneous T-cell Lymphoma
    Hollins, L. Claire
    Wirth, Paul
    Fulchiero, Gregory J., Jr.
    Foulke, Galen T.
    [J]. CUTIS, 2020, 106 (02): : E8 - E11
  • [8] Diagnosis of mycosis fungoides or Sezary syndrome after dupilumab use: A systematic review
    Jfri, Abdulhadi
    Smith, Jeffrey S.
    Larocca, Cecilia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1164 - 1166
  • [9] Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
    Kolkowski, Karol
    Trzeciak, Magdalena
    Sokolowska-Wojdylo, Malgorzata
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [10] Cutaneous T-cell Lymphoma and Concomitant Atopic Dermatitis Responding to Dupilumab
    Mollanazar, Nicholas K.
    Savage, Kevin T.
    Pousti, Bobak T.
    Jariwala, Neha
    Del Guzzo, Christina
    Haun, Paul
    Vittorio, Carmela C.
    Rook, Alain H.
    Kim, Ellen J.
    [J]. CUTIS, 2020, 106 (03): : 131 - 132
12